Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1001965

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many sites currently provide the HPV vaccine to gay and bisexual men by region.
tabling member constituency	Plymouth, Sutton and Devonport
tabling member printed	Luke Pollard
uin	188248
answer	answer is ministerial correction date of answer 15/11/2018 answer text <p>The human papillomavirus vaccination programme for men that have sex with men is being introduced via a phased rollout. There are approximately 233 HIV and sexual health clinics nationally and 151 of these are already offering the programme. NHS England anticipates that rollout will be complete by next year. Of the 151 clinics offering the vaccine 33 are in the North; 45 in the Midlands and East; 36 in the South and 37 in London.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/11/2018 12:32:41 answering member 4067 label Biography information for Steve Brine
tabling member	4682 label Biography information for Luke Pollard

1001966

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the uptake has been of the HPV vaccine for gay and bisexual men by region since April 2018.
tabling member constituency	Plymouth, Sutton and Devonport
tabling member printed	Luke Pollard
uin	188249
answer	answer is ministerial correction date of answer 15/11/2018 answer text <p>Data on the human papillomavirus vaccine uptake since April 2018 is not available at this time.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/11/2018 12:43:59 answering member 4067 label Biography information for Steve Brine
tabling member	4682 label Biography information for Luke Pollard

964862

registered interest
date	03/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many sexual health clinics currently provide the HPV vaccine bisexual men; and what the timeframe is for the completion of the roll-out of the HPV vaccine programme to (a) gay and (b) bisexual men.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	169182
answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The human papillomavirus vaccination programme for men that have sex with men is being introduced via a phased rollout. There are approximately 230 HIV and sexual health clinics nationally and around 75 of these are already offering the programme. NHS England anticipate that rollout will be complete by April 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 16:10:04 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

947667

registered interest
date	24/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with appropriate officials in Northern Ireland on extending access to the HPV vaccination to that part of the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	168062
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>Health is a devolved matter and therefore any decision regarding this programme has to be taken by a Northern Ireland Health Minister.</p><p> </p><p>The four United Kingdom Health Departments are in regular contact on a range of issues including this programme. They will continue to discuss and share information while a decision is pending in Northern Ireland.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:46:40 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

944052

registered interest
date	18/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to make an announcement on the roll-out of HPV vaccination for boys.
tabling member constituency	North Thanet
tabling member printed	Sir Roger Gale
uin	165437
answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>The advice of the Joint Committee on Vaccination and Immunisation on whether or not to have a human papilloma virus vaccination programme for boys was published on 18 July 2018.</p><p> </p><p>A decision will be announced very soon.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/07/2018 15:00:57 answering member 4067 label Biography information for Steve Brine
tabling member	87 label Biography information for Sir Roger Gale

924159

registered interest
date	14/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, following the recent meeting of the Joint Committee on Vaccinations and Immunisation (JCVI), whether they have received a recommendation from the JCVI regarding the extension of the human papillomavirus vaccination to all boys; and if so, when they will announce their decision in this regard.
tabling member printed	Baroness Altmann
uin	HL8638
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The Department has not yet received the Joint Committee on Vaccination and Immunisation’s final advice on human papillomavirus vaccination for boys. The Department expects to receive this advice imminently and will consider this as a matter of priority. A decision will be made as soon as possible.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:13:47 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4533 label Biography information for Baroness Altmann

924160

registered interest
date	14/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what is the Joint Committee on Vaccination and Immunisation's latest assessment of the proportion of cancers which are caused by vaccine-preventable types of human papillomavirus.
tabling member printed	Baroness Altmann
uin	HL8639
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published an interim statement on extending the human papillomavirus (HPV) vaccination to adolescent boys in July 2017. The interim statement and the following table set out the proportion of cancers attributable to HPV infection by disease, as modelled by Public Health England (PHE). A copy of the JCVI Interim Statement on Extending HPV Vaccination to Adolescent Boys is attached.</p><p> </p><table><tbody><tr><td><p>Cancer site (females)</p></td><td><p>High-risk HPV type (attribution fraction)</p></td></tr><tr><td><p>Cervix</p></td><td><p>HPV16/18/31/33/45/52/58/other (35/39/51/56/59/68) (95.1%)</p></td></tr><tr><td><p>Vulva</p></td><td><p>HPV16/18/33 (12.7%)</p></td></tr><tr><td><p>Vagina</p></td><td><p>HPV16 (53.7%)</p></td></tr><tr><td><p>Anus</p></td><td><p>HPV16/18/33 (77.0%)</p></td></tr><tr><td><p>Oropharynx</p></td><td><p>HPV16 (24.7%)</p></td></tr><tr><td><p>Oral cavity</p></td><td><p>HPV16/18 (1.1%)</p></td></tr><tr><td><p>Larynx</p></td><td><p>HPV16/18 (1.9%)</p></td></tr></tbody></table><p> </p><table><tbody><tr><td><p>Cancer site (males)</p></td><td><p>High-risk HPV type (attribution fraction)</p></td></tr><tr><td><p>Anus</p></td><td><p>HPV16/18/33 (77.0%)</p></td></tr><tr><td><p>Penis</p></td><td><p>HPV16/18 (28.6%)</p></td></tr><tr><td><p>Oropharynx</p></td><td><p>HPV16 (12.8%)</p></td></tr><tr><td><p>Oral cavity</p></td><td><p>HPV16/18 (1.4%)</p></td></tr><tr><td><p>Larynx</p></td><td><p>HPV16/18 (0.6%)</p></td></tr></tbody></table><p> </p><p>Note:</p><p> </p><p>Attributable fraction for high risk HPV types associated with cancer as modelled by PHE and based on International Agency for Research on Cancer reviews.</p><p> </p><p>The JCVI most recently considered HPV vaccination on 6 June 2018, and the minutes of that meeting will be published on or before 18 July 2018.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:06:23 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name Extending_HPV_Vaccination.pdf title Extending_HPV_Vaccination
tabling member	4533 label Biography information for Baroness Altmann

923139

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what is the rate of ectropions in the cohorts who received human papilloma virus vaccinations.
tabling member printed	The Countess of Mar
uin	HL8603
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Data are not collected on the rate of ectropions in the cohorts who received human papillomavirus vaccinations.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:12:23 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

923140

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what is the efficacy of the human papilloma virus (HPV) vaccination programme in women and girls who may already have had exposure to HPV infection, either naturally or as the result of sexual abuse, prior to receiving that vaccine.
tabling member printed	The Countess of Mar
uin	HL8604
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The human papillomavirus (HPV) vaccines have demonstrated very high vaccine efficacy against the vaccine types and related disease in clinical trials when administered to HPV-naïve women (i.e. women with no current or previous vaccine-type HPV infection). However, results from these trials also demonstrated that HPV vaccination of women with a current vaccine-type HPV infection had little or no effect on clearance of the existing infection. There is also some evidence of a slightly reduced vaccine efficacy against pre-cancerous abnormalities among young women currently not infected with HPV but with serological evidence of a previous exposure.</p><p> </p><p>Public Health England has conducted surveillance to monitor the prevalence of type-specific genital HPV infections in 16-24 year old sexually active women in England who would have been eligible to receive the HPV vaccine. The latest data, including specimens collected to the end of 2016, demonstrated a vaccine effectiveness of 82.0% against infections with HPV16/18 among women vaccinated at age 15 years or younger. The vaccine effectiveness in women who would have been vaccinated at age 16 to 18 years old was 48.7%. This suggests that the vaccine works best when given to young girls before they are exposed to HPV. However it also shows that older girls still benefit from vaccination.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 16:37:27 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

923141

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what action they are taking to ensure that the cohort of women who have received human papilloma virus vaccinations are aware that they should still attend cervical smear test appointments.
tabling member printed	The Countess of Mar
uin	HL8605
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The human papillomavirus (HPV) vaccination programme states in patient communications that cervical screening (smear tests) will continue to be important whether women have had the HPV vaccine or not. Women aged 25 to 64 who are registered with a general practitioner are automatically invited for cervical screening. This includes women who have had the HPV vaccination as the vaccine does not guarantee completed protection of against all high risk strains of HPV. The importance of cervical screening is also reiterated online on NHS Choices.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:12:00 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar